Subgroup analysis revealed that a higher Eastern Cooperative Oncology Group Performance Status (ECOG) score, the presence of chronic obstructive pulmonary disease (COPD), and TP53 mutation status were markedly linked with reduced PFS. The gene discussed is TP53; the disease is chronic obstructive pulmonary disease.